Introduction: Colon cancer is one of the major human malignancies worldwide, and much
effort has been applied to understand the process of colon carcinogenesis, as well as the …

Fluoxetine (FLX) is a drug commonly used as antidepressant. However, its effects on
tumorigenesis remain controversial. Aiming to evaluate the effects of FLX treatment on early …

The antidepressant fluoxetine has been under discussion because of its potential influence
on cancer risk. It was found to inhibit the development of carcinogen-induced preneoplastic …

Colon cancer is one of the most common tumors in the human population. Recent studies
have shown a reduced risk for colon cancer in patients given the antidepressant fluoxetine …

The antidepressant fluoxetine has been under discussion because of its potential influence
on cancer risk. It was found to inhibit the development of carcinogen-induced preneoplastic …

Colon cancer is one of the most common tumors worldwide, with increasing incidence in
developing countries. Patients treated with fluoxetine (FLX) have a reduced incidence of …

Fluoxetine (FLX) is a selective serotonin reuptake inhibitor (SSRI), and was discovered by a
research group from the Eli Lilly Company in 1974 [1]. It is a lipophilic weak base …

Fluoxetine (FLX) is a widely prescribed antidepressant. Concerns were raised about the
potential impact of FLX on cancer growth, because FLX was shown to promote development …

Abstract Fluvoxamine's (FLX's) anticancer potential was investigated in pre-clinical research
utilizing a DMH-induced colorectal cancer (CRC) rat model. qRT-PCR and immunoblotting …

The enhanced chemopreventive action against 1, 2 Dimethylhydrazine (DMH)-induced
preneoplastic lesion in rats could be achieved via simultaneous administration of the …